The one-year certification confirms foundational cybersecurity practices across the company’s agentic platform.
Hippocratic AI, which has developed a safety-focused large language model for healthcare, announced it has attained HITRUST e1 Certification, covering the company’s full agentic platform.
Achieving HITRUST certification is widely regarded as a gold standard for healthcare cybersecurity, demonstrating an organization’s commitment to safeguarding protected health information. The HITRUST e1 certification, known as the “HITRUST Essentials, 1-Year” assessment, encompasses the 44 most critical security controls and provides a one-year validated certification.
Achieving the certification means Hippocratic AI has implemented foundational cybersecurity practices and had them independently validated, offering assurance that robust data protection measures are in place. “Security and patient safety have always been top priorities for Hippocratic AI, and attaining HITRUST certification validates that commitment,” says Matt Honea, chief information security officer at Hippocratic AI, in a release. “As we empower healthcare organizations with our AI platform, this certification assures them that we uphold the highest industry standards for protecting sensitive data and maintaining their trust.”
The HITRUST e1 certification comes as Hippocratic AI continues to innovate with a safety-first approach to generative AI in healthcare. The company provides specialized generative AI agents that perform non-diagnostic, patient-facing outreach. Hippocratic AI’s proprietary Polaris constellation architecture has demonstrated high clinical accuracy and has powered over 2.5 million patient calls, while achieving a high patient satisfaction rate of 8.95/10. B
The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA’s NVentures, Premji Invest, SV Angel, and six health systems.
ID 151316686 © Alexandersikov | Dreamstime.com
